PUBLISHED ON: April 28, 2011 | Duration: 8 min, 08 sec
Kiran Majumdar Shaw, MD of Biocon announces divestment of 70% in the company's German arm - Axicorp GmbH following its global alliance with Pfizer for commercialisation of biosimilar insulin and insulin analogs.
